Can Select Medical Holdings cover its short-term obligations?

Its current ratio is 1.15 — current assets exceed current liabilities.

Where does Select Medical Holdings's balance sheet data come from?

Every line is extracted from Select Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Select Medical Holdings SEM Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$26.52M-55.6%	$59.69M-28.9%	$84.01M-14.2%	$97.91M+31.8%
Accounts receivable, net	$864.21M+5.2%	$821.39M+13.4%	$724.14M-23.1%	$941.31M+5.8%
Prepaid expenses and other current assets	$114.93M+2.5%	$112.1M-3.4%	$116.1M-7.4%	$125.37M+4.3%
Income taxes receivable	$19.62M-26.2%	$26.6M+80.4%	$14.75M-53.7%	$31.87M-42.7%
Total current assets	$1.03B+0.5%	$1.02B-18.9%	$1.26B-1.1%	$1.27B+11.6%
Property and equipment, net	$992.31M+13.8%	$872.19M-14.8%	$1.02B+2.2%	$1B+4.2%
Operating lease right-of-use assets	$957.9M+5.5%	$908.1M+14.8%	$790.76M-32.4%	$1.17B+8.4%
Goodwill	$2.36B+1.2%	$2.33B+2.1%	$2.28B+1.1%	$2.26B-34.5%
Intangible assets, net	$100.8M-2.3%	$103.18M-1.9%	$105.15M-70.1%	$351.66M-6.2%
Deferred tax assets	$112.16M+37.6%	$81.5M-32.1%	$119.94M-29.4%	$169.79M+18.9%
Other non-current assets	$414.39M+11.2%	$372.81M+1.2%	$368.32M+7.8%	$341.74M+0.9%
Total assets	$5.85B+4.3%	$5.61B-27.1%	$7.69B+0.3%	$7.67B+4.1%
Accounts payable	$157.06M+10.5%	$142.16M-7.6%	$153.9M-17.6%	$186.73M-20.1%
Accrued expenses	$274.08M-5.1%	$288.68M-3.0%	$297.66M+12.5%	$264.53M+8.2%
Current portion of long-term debt	$24.22M+19.5%	$20.27M-70.6%	$68.87M+55.3%	$44.35M+152%
Operating lease liabilities, current	$188.41M+4.9%	$179.6M+4.1%	$172.45M-27.2%	$236.78M+3.2%
Income taxes payable	$1.23M-81.5%	$6.64M+343%	$1.5M+212%	$480K-66.6%
Accrued interest	$4.3M-52.6%	$9.08M-72.1%	$32.47M+8.8%	$29.84M+2.9%
Total current liabilities	$984.49M+0.7%	$977.65M-21.7%	$1.25B+8.1%	$1.16B-9.3%
Long-term debt	$1.8B+6.6%	$1.69B-52.8%	$3.58B-6.5%	$3.84B+7.8%
Operating lease liabilities, non-current	$835.36M+6.1%	$787.12M+17.7%	$668.56M-33.7%	$1.01B+10.0%
Other non-current liabilities	$79.86M+9.3%	$73.04M-11.8%	$82.78M-22.0%	$106.14M-0.3%
Total liabilities	$3.82B+5.7%	$3.61B-41.0%	$6.12B-2.5%	$6.27B+4.7%
Common stock	700M+542,536%	129K+0.8%	128K+0.8%	127K-5.2%
Additional paid-in capital	$874.85M-4.0%	$911.08M+84.6%	$493.41M+9.1%	$452.18M-10.3%
Retained earnings	$837.02M+8.7%	$770.15M+2.4%	$751.86M+29.4%	$581.01M-2.1%
Accumulated other comprehensive income (loss)	-$6.4M—	$0-100%	$42.91M-51.6%	$88.6M+621%
Redeemable noncontrolling interests	$18.81M+85.0%	$10.17M-61.3%	$26.3M-22.8%	$34.04M-12.8%
Noncontrolling interests	$311.35M+1.9%	$305.57M+17.8%	$259.41M+10.6%	$234.64M+8.7%
Total stockholders' equity	$1.71B+1.4%	$1.68B+30.5%	$1.29B+14.8%	$1.12B+1.1%
Total liabilities and stockholders' equity	$5.85B+4.3%	$5.61B-27.1%	$7.69B+0.3%	$7.67B+4.1%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$26.52M-55.6%	$59.69M—	——	——
Other current assets	$114.93M+2.5%	$112.1M-3.4%	$116.1M-7.4%	$125.37M+4.3%
Deferred Tax Assets and Other Non-Current Assets	$414.39M+11.2%	$372.81M+1.2%	$368.32M+7.8%	$341.74M+0.9%
Net Investment in Lease	$957.9M+5.5%	$908.1M+14.8%	$790.76M-32.4%	$1.17B+8.4%
Other intangible assets—net	$100.8M-2.3%	$103.18M-1.9%	$105.15M-70.1%	$351.66M-6.2%
Operating lease right-of-use assets	$957.9M+5.5%	$908.1M+14.8%	$790.76M-32.4%	$1.17B+8.4%
Other non-current assets	$414.39M+11.2%	$372.81M+1.2%	$368.32M+7.8%	$341.74M+0.9%
Property, plant and equipment, net	$992.31M+13.8%	$872.19M+3.2%	$845.19M—	——
Operating Lease Right-of-Use Assets in Other Assets	$957.9M+5.5%	$908.1M+14.8%	$790.76M-32.4%	$1.17B+8.4%
Software and Technology Licenses, Net	$414.39M+11.2%	$372.81M+1.2%	$368.32M+7.8%	$341.74M+0.9%
Accrued liabilities and other current	$598.06M-1.9%	$609.82M+10.5%	$551.68M—	——
Accrued Vacation Current	$129.47M+5.8%	$122.38M-22.4%	$157.75M+4.7%	$150.7M+4.6%
Overdrafts	$16.75M-35.1%	$25.8M-14.8%	$30.27M-5.3%	$31.96M-24.5%
Current Portion of Long-Term Debt and Finance Lease Obligations	$24.22M+19.5%	$20.27M-70.6%	$68.87M+55.3%	$44.35M+152%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$14.93M-11.0%	$16.77M+49.4%	$11.23M-29.2%	$15.85M-25.0%
Long-Term Debt and Finance Lease Obligations	$1.8B+6.6%	$1.69B-52.8%	$3.58B-6.5%	$3.84B+7.8%
Long-Term Debt - Fair Value	$1.83B+7.0%	$1.71B-53.4%	$3.67B-2.7%	$3.77B+3.8%
Total debt	$2.92B+8.5%	$2.69B-40.3%	$4.51B-12.4%	$5.14B+8.5%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	124M-3.8%	129M+0.5%	128.4M+0.9%	127.2M-5.0%
Additional paid-in capital	$874.85M-4.0%	$911.08M+84.6%	$493.41M+9.1%	$452.18M-10.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$124K-3.9%	$129K+0.8%	$128K+0.8%	$127K-5.2%
Interest Rate Hedge Reclassification (Next 12 Months)	——	——	——	——
Accrued payroll	$188.98M+3.2%	$183.05M-23.3%	$238.77M+13.8%	$209.79M-15.2%
Cash and cash equivalents, end of period	$26.52M-55.6%	$59.69M—	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$700M0.0%	$700M0.0%	$700M0.0%	$700M0.0%
Common stock, shares issued (in shares)	$124.02M-3.8%	$128.96M+0.5%	$128.37M+0.9%	$127.17M-5.0%
Common Stock, Shares, Outstanding	$124.02M-3.8%	$128.96M+0.5%	$128.37M+0.9%	$127.17M-5.0%
Debt Instrument, Fair Value Disclosure	$1.83B+7.0%	$1.71B-53.4%	$3.67B-2.7%	$3.77B+3.8%
Debt Instrument, Unamortized Discount (Premium), Net	$2.29M-14.9%	$2.69M+177%	-$3.49M+79.7%	-$17.18M+19.2%
Deferred income taxes	$112.16M+37.6%	$81.5M-32.1%	$119.94M-29.4%	$169.79M+18.9%
Gains expected to be reclassified	——	——	——	——
Long-Term Debt and Lease Obligation	$1.8B+6.6%	$1.69B-52.8%	$3.58B-6.5%	$3.84B+7.8%
Less: current maturities	$24.22M+19.5%	$20.27M-70.6%	$68.87M+55.3%	$44.35M+152%
Long-Term Debt And Finance Lease Obligation	$1.83B+6.8%	$1.71B-53.2%	$3.66B-5.7%	$3.88B+8.6%
2028	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
2030	——	——	——	——
Thereafter	——	——	——	——
2026	——	——	——	——
Principal Outstanding	$1.85B+6.6%	$1.73B-52.8%	$3.67B-5.5%	$3.88B+8.5%
Equity financing commitment amount	——	——	——	——
Merger consideration per share amount (in dollars per share)	——	——	——	——
Termination fee payable to parent	——	——	——	——
Termination fee receivable from parent	——	——	——	——
Noncontrolling interests in subsidiaries	$311.35M+1.9%	$305.57M+17.8%	$259.41M+10.6%	$234.64M+8.7%
Other accrued liabilities	$274.08M-5.1%	$288.68M-3.0%	$297.66M+12.5%	$264.53M+8.2%
Redeemable noncontrolling interests in subsidiaries	$18.81M+85.0%	$10.17M-61.3%	$26.3M-22.8%	$34.04M-12.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Select Medical Holdings cover its short-term obligations?: Its current ratio is 1.15 — current assets exceed current liabilities.
Where does Select Medical Holdings's balance sheet data come from?: Every line is extracted from Select Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.